MedTrace Logo

Resistant Hypertension in Patients With Type-II-Diabetes Mellitus

NCT01056367 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180

Last updated 2011-10-12

No results posted yet for this study

Summary

The risk of cardiovascular disease (CVD) in patients with type-II-diabetes mellitus (type-II-DM)is more than doubled and CVD accounts for 70% of deaths in this group of patients.

Hypertension is a major risk factor for CVD in patients with type-II-DM and a major contributor cardiovascular mortality. Uncontrolled- (UH) and resistant hypertension (RH)are more common in patients with type-II-DM, why further bloodpressure (BP) control is needed.

The prevalence of UH and RH has not been examined in a consecutive Danish outpatient population with type-II-DM.

The purpose of this study is to examine the prevalence of resistant hypertension in patients with type-II-diabetes and to examine the characteristics of patients with resistant hypertension as compared to patients with controlled hypertension with regards to arterial stiffness.

Conditions

  • Resistant Hypertension
  • NIDDM

Sponsors & Collaborators

  • Svendborg Hospital

    lead OTHER

Principal Investigators

  • Trine K Sønder, Cand.med. · Department of Medical Research, Svendborg Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-07-31
Completion
2011-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01056367 on ClinicalTrials.gov